Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition
11:07am, Monday, 20'th Apr 2026
Eli Lilly and Co (NYSE:LLY) has agreed to acquire private clinical-stage biotechnology firm Kelonia Therapeutics in a deal aimed at expanding its capabilities in genetic medicines, the companies annou
Live Nasdaq Composite: Markets Mixed on Mideast Uncertainty as Apple Captures $4T Market Cap
10:45am, Monday, 20'th Apr 2026
Live Updates The analyst who called NVIDIA in 2010 just named his top 10 AI stocks Wall Street is pouring billions into AI, but most investors are buying the wrong stocks. The analyst who first identi
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Monday, 20'th Apr 2026
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Eli Lilly to acquire Kelonia in $7 billion cancer therapy push
09:28am, Monday, 20'th Apr 2026
Eli Lilly said on Monday it will acquire privately held Kelonia Therapeutics in a deal worth up to $7 billion, as the drugmaker deepens its presence in next-generation cancer treatments. The agreement
Stock Market Today (LIVE): Adobe Taps Rivals to Save Its Moat; Markets Wobble on New Iran Tensions
09:09am, Monday, 20'th Apr 2026
Top insights from the latest market news from Monday, April 20, from The Motley Fool analysts on Team Rule Breakers and Team Hidden Gems.
Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion
09:02am, Monday, 20'th Apr 2026
Eli Lilly said it has agreed to acquire biotech company Kelonia Therapeutics. Lilly will pay $3.25 billion upfront and up to $7 billion in total, the company said.
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
09:00am, Monday, 20'th Apr 2026
Kelonia's lead program, KLN-1010, is a potentially first-in-class lentiviral in vivo CAR-T therapy currently in Phase 1 for relapsed/refractory multiple myeloma with clinical data recently highlighted
Eli Lilly Stock Falls as It Closes in on a $2 Billion Deal. Here's Why.
07:41am, Monday, 20'th Apr 2026
Eli Lilly's deal for Kelonia, which develops blood cancer therapies, could come as early as Monday.
Pursuit Wealth Management LLC Takes Position in Eli Lilly and Company $LLY
07:24am, Monday, 20'th Apr 2026
Pursuit Wealth Management LLC purchased a new stake in Eli Lilly and Company (NYSE: LLY) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange
Mirae Asset Global Investments Co. Ltd. Purchases 28,130 Shares of Eli Lilly and Company $LLY
07:24am, Monday, 20'th Apr 2026
Mirae Asset Global Investments Co. Ltd. raised its position in Eli Lilly and Company (NYSE: LLY) by 11.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC
Means Investment CO. Inc. Sells 564 Shares of Eli Lilly and Company $LLY
07:24am, Monday, 20'th Apr 2026
Means Investment CO. Inc. trimmed its position in shares of Eli Lilly and Company (NYSE: LLY) by 10.8% during the undefined quarter, according to its most recent Form 13F filing with the Securities an
Eli Lilly and Company $LLY Shares Sold by Private Trust Co. NA
06:50am, Monday, 20'th Apr 2026
Private Trust Co. NA decreased its position in Eli Lilly and Company (NYSE: LLY) by 6.4% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and E
Greenwood Capital Associates LLC Sells 744 Shares of Eli Lilly and Company $LLY
06:10am, Monday, 20'th Apr 2026
Greenwood Capital Associates LLC trimmed its position in Eli Lilly and Company (NYSE: LLY) by 5.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange
Cwm LLC Grows Stake in Eli Lilly and Company $LLY
04:20am, Monday, 20'th Apr 2026
Cwm LLC lifted its stake in shares of Eli Lilly and Company (NYSE: LLY) by 39.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The in
Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
05:33pm, Sunday, 19'th Apr 2026
Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, the Wall Street Journal reported on Sunday.
